Navigation Links
Twinfield

ProductsTwinfield
Company Oculus, Inc.
Item Twinfield
Features Twinfield gives you perfectly round Goldmann standard stimuli presented on a 30 cm radius bowl for greater precision. A dedicated CCD camera for fixation control. Adjustable stimulus, size and luminance. The modular design simplifies maintenance (no test point lamp to change). An adjustable head and motorized chin rest, and ergonomic arm rests ensure patient comfort and compliance. And a Windows environment, run off your laptop or PC, makes it easy to operate.
Description Goldmann standard automatic or manual kinetic and static perimetry. Color perimetry with white/white, blue/yellow or red/white stimuli/background colors. Static perimetry with supra, fast or classic 4-2 threshold strategy. Examination with pre-programmed or hand-picked test point grids (including 30-2, 24-2, and 10-2). Gray-scale/ Scotoma curve, overview, profile, even 3D animation displays. New, faster optimal "CLIP" strategy also available. Introducing the ultimate full field perimeter.
Info Oculus, Inc.
Customer Service: (888) 284-8004

Related medicine products :

1. Centerfield 2
TAG: Twinfield
Bandeau Bra
Bras and Breast Support
Compression Bra
Constructed from soft Shur-grip foam and velcro closure for easy application and - reapplication
Medicine Products:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
... of a job burn out. Apart from it affecting produc...of ailments, say Scientists. //This study supports...at stress at work can contribute to high blood pre...art disease. A study of 677 workers in Israel rev...
... of Obstetrics, Gynecology & Reproductive Sciences...n //College of Medicine report that women who are ... sensation and were more likely to complain of pai...undertook a comparative study between 48 women com...
...ifer Aniston says yoga helped her deal with her sp...was able to get her mind and body back in shape, a... she needed to move" before she commenced with yog...as in need of being scooped up". Aniston also lis...
...ing use of contaminated drug syringes are the main...st India and also in major cities like// Delhi, Mu...edge of HIV has been found in groups of men who ha...ple, three in four men who have sex with men did n...
Other Medicine News:Health News:Competitive women cyclists experience reduced genital sensation 2Health News:Homosexuality, drug abuse increasing HIV in India: study 2
(Date:10/7/2008)...tage A of Trial Assessing Regimen of Bavituxima..., TUSTIN, Calif., Oct. 7 /..., a clinical stage biopharmaceutical,company devel...ancer and,hepatitis C virus (HCV) infection, today... first stage of a Phase II trial of bavituximab in...
(Date:10/6/2008)...ollege of Gastroenterology Annual ...Newswire/ -- Combined results from two Phase 3,stu...terology Annual,Scientific Meeting (ACG) in Orland...igher healing rates than lansoprazole among patien...(EE). TAK-390MR combines,dexlansoprazole with a Du...
(Date:10/6/2008)...te to Improve Patient Safety, WASHINGTON, Oct. 6 ...,Cardiology in collaboration with the American Col...sociation today released consensus guidelines,outl... ulcers and,gastrointestinal (GI) bleeding among p... (NSAIDs) along with antiplatelet agents., Gastro...
(Date:10/6/2008).... 6 /- Complete,Genomics Inc., a newl...ng,company, and the Institute for Systems Biology ... populationwide human genome studies., In phase o...proprietary,DNA sequencing technology to sequence ...nce proof-of-concept has been demonstrated, ISB an...
Breaking Medicine Technology:Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed 2Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 4Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2125 Indevus Sales Representatives to Provide Community Service in New Orleans for Jericho Road Episcopal Housing Initiative 4101 1125 Indevus Sales Representatives to Provide Community Service in New Orleans for Jericho Road Episcopal Housing Initiative 4101 2125 Indevus Sales Representatives to Provide Community Service in New Orleans for Jericho Road Episcopal Housing Initiative 4101 3125 Indevus Sales Representatives to Provide Community Service in New Orleans for Jericho Road Episcopal Housing Initiative 4101 4Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference 4097 1Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference 4097 2Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference 4097 3Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference 4097 4New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 1567 1New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 1567 2New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 1567 3New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 1567 4New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 1567 5New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 1567 6New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly 1567 7LUMEDX Updates Real Time Patient and Resource Scheduler for Healthcare Systems 4095 1LUMEDX Updates Real Time Patient and Resource Scheduler for Healthcare Systems 4095 2
...lyses To Be Presented --, SAN FRANCISCO, April 24,...oday announced that data from the Company,s Phase,...ease will be,presented for the first time in the U...s 59th Annual Meeting in Boston on Thursday,May 3... include new,data from both the mild and moderate ...
...., April 24, 2007 /PRNewswire/ -- Accera Inc.,anno...tudy of its,lead compound AC-1202 in Alzheimer,s d...g of the American Academy of Neurology (AAN) in,Bo...ent of the,program, the data will also be featured...ccera,s vice president of clinical development Dr....
Other Medicine Technology:Medivation Announces First U.S. Presentation of Data From Dimebon,Phase 2 Alzheimer's Disease Trial at American Academy of Neurology,Annual Meeting 2Medivation Announces First U.S. Presentation of Data From Dimebon,Phase 2 Alzheimer's Disease Trial at American Academy of Neurology,Annual Meeting 3Accera, Inc. to Present Results of Phase II Study in Alzheimer's,Disease at American Academy of Neurology Meeting 2